Beta Bionics Inc. BBNX
$13.79
▼ -1.09% 24H
About
Beta Bionics Inc. is a commercial-stage medical device company focused on designing, developing, and commercializing advanced solutions to improve the health and quality of life for people requiring insulin due to diabetes. Its flagship product, the iLet Bionic Pancreas, is an FDA-cleared automated insulin delivery sys…
SectorHealthcare
ExchangeNASDAQ
IndustryMedical Devices
CountryUnited States
Employees420
TickerBBNX
Statistics
Market Cap$614.5M
Revenue (TTM)$100.3M
Net Income-$73.2M
Net Margin-73.0%
EPS$-1.81
P/E-7.97
P/S5.94
P/B2.41
EV/EBITDA-5.55
ROE-22.7%
Dividend Yield—
Price$13.79
Data: Twelve Data · Revenue = mcap / P/S